Navigation Links
CRH Medical reports Q2 2008 results
Date:8/28/2008


- Revenues increase 138% versus Q2 2007

- Nine new Centers opened to date in 2008

VANCOUVER, Aug. 28 /PRNewswire-FirstCall/ - CRH Medical Corporation (CRM:TSX-V) announced today unaudited results for the three and six months ended June 30, 2008 (all figures are in US dollars). Revenue for the three months ended June 30, 2008 increased 138% to $1,653,891 compared to $695,994 for the same period in 2007. Revenue for the six months ended June 30, 2008 increased 150% to $3,001,333 compared to $1,202,048 for the same period in 2007. The Company recorded a net loss of $1,097,973 ($0.02 per share) and $2,056,711 ($0.05 per share) for the three and six months ended June 30, 2008 compared to a net loss of $773,785 ($0.02 per share) and $1,950,824 ($0.05 per share) for the same periods in 2007. Additionally, the Company announced that as of June 30, 2008 it had $1.976 million in cash and cash equivalents and working capital of $2.986 million.

The Company also announced that for the three months ended June 30, 2008, it had 6,496 patient visits at its Centers for Colorectal Health compared to 2,859 patient visits for the same period in 2007.

Commenting on the second quarter, 2008 results, Edward Wright, Chief Executive Officer stated, "The addition of nine new centers opened to date in 2008 continues to demonstrate our ability to expand the Centers for Colorectal Health network. Additionally our direct to physician initiative, whereby we provide training and support for physicians purchasing our technology, is garnering strong momentum. These two strategies enable greater accessibility to our technology and treatment protocols which we expect will provide significant revenue growth."

Summary of interim results (expressed in United States dollars):

Consolidated Balance Sheet

-------------------------------------------------------------------------

June 30, December 31,

2008 2007

-------------------------------------------------------------------------

Current assets:

Cash and cash equivalents $ 1,975,571 $ 3,531,818

Accounts receivable 1,452,086 975,290

Inventory 53,669 30,716

Prepaid expenses and deposits 170,888 262,084

-----------------------------------------------------------------------

3,652,214 4,799,908

Property and equipment 871,710 879,394

Intellectual property 696,739 734,293

-------------------------------------------------------------------------

$ 5,220,663 $ 6,413,595

Current liabilities:

Accounts payable and accrued liabilities $ 624,986 $ 323,791

Deferred leasehold inducements 41,426 41,426

-----------------------------------------------------------------------

666,412 365,217

Deferred leasehold inducements 80,571 98,729

Shareholders' equity:

Share capital (note 6) 14,999,482 14,933,072

Contributed surplus (note 6) 2,919,956 2,405,624

Accumulated other comprehensive loss (66,772) (66,772)

Deficit (13,378,986) (11,322,275)

-----------------------------------------------------------------------

4,473,680 5,949,649

-------------------------------------------------------------------------

$ 5,220,663 $ 6,413,595

-------------------------------------------------------------------------

-------------------------------------------------------------------------

Consolidated Statements of Operations, Comprehensive Loss and Deficit

-------------------------------------------------------------------------

Three months ended Six months ended

-------------------------- -------------------------

June 30, June 30, June 30, June 30,

2008 2007 2008 2007

-------------------------------------------------------------------------

Revenue:

Center

operations $ 1,504,072 $ 646,700 $ 2,797,640 $ 1,099,617

Product sales 149,819 49,294 203,693 102,431

-----------------------------------------------------------------------

1,653,891 695,994 3,001,333 1,202,048

Expenses:

Center

operations

and development 1,890,804 1,073,035 3,436,221 2,241,578

Medical products 143,336 84,473 214,932 142,119

Corporate and

other 640,103 569,702 1,253,735 1,017,282

Depreciation

and

amortization 88,325 72,665 175,592 137,331

-----------------------------------------------------------------------

2,762,568 1,799,875 5,080,480 3,538,310

Operating loss (1,108,677) (1,103,881) (2,079,147) (2,336,262)

Other items:

Interest income 13,439 41,548 34,237 83,574

Foreign exchange

gain (loss) (4,226) 288,548 (13,912) 301,864

Other income 1,491 - 2,111 -

-----------------------------------------------------------------------

10,704 330,096 22,436 385,438

Net loss and

comprehensive

loss (1,097,973) (773,785) (2,056,711) (1,950,824)

Basic and diluted

loss per share $ (0.02) $ (0.02) $ (0.05) $ (0.05)

Weighted average

shares

outstanding 44,878,418 43,177,351 44,801,334 43,054,684

-------------------------------------------------------------------------

-------------------------------------------------------------------------

About CRH Medical Corporation:

CRH Medical Corporation is utilizing the first single use, patented, disposable, hemorrhoid banding system through its Center for Colorectal Health facilities. According to the National Institute of Health approximately 50% of the U.S. population will develop hemorrhoids by age 50. CRH Medical is opening its Center for Colorectal Health facilities in the United States specializing in the treatment of hemorrhoids, anal fissures, and colon cancer screening and plans to significantly increase the number of Centers for Colorectal Health across the U.S. to address this underserved market. The Company's goal is to become the preeminent resource on colorectal health for consumers and medical professionals in North America.

The information in this news release contains so-called "forward-looking" statements. These include statements regarding CRH Medical expectations, beliefs, intentions or strategies for the future, which may be indicated by words or phrases such as "anticipate", "expect", "intend", "plan", "will", "we believe", "CRH Medical believes", "management believes" and similar language. All forward-looking statements are based on CRH Medical current expectations and are subject to risks and uncertainties and to assumptions made.

The TSX Venture Exchange does not accept responsibility for the adequacy

or accuracy of this release.


'/>"/>
SOURCE CRH Medical Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Frost & Sullivan Honours Redsense Medical With the 2008 European Hemodialysis Emerging Company of the Year Award
2. Lenaye Lawyer, MD, FACOG, Named KePRO Medical Director
3. ReachMD, LLC Announces New Strategic Partnership With The American Medical Student Association
4. University Hospitals Case Medical Center recognized by American Heart Association
5. Shaping Best Practices For Standardized Medical Imaging In Clinical Trials
6. NitiBrite™ - Break-through in Nitinol Wire Product for Medical Devices
7. Medical Records Institute Unveils Platform for Studying Cell Phone Applications in Healthcare
8. Hartwell Medical Announces Release of CombiCarrierII Scoop Backboard to EMS Market
9. Greenway Medical Technologies Growth Continues with Significant Fiscal Year 2008 Gains
10. First Major Medical Meeting Convening for MRI-guided Focused Ultrasound to Treat Cancer, Stroke, Fibroids, Other Conditions
11. iCan Benefit Group, LLC Announces: Major Medical Division Now Offers Avalon Healthcare Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... 05, 2016 , ... Qrono Inc. , a specialty ... collaboration with the Australian critical medicine company, Phebra Pty Ltd. , to ... medicines can offer improved therapeutic benefits over oral formulations, including better bioavailability, improved ...
(Date:5/5/2016)... ... , ... Einstein Medical is proud to announce that it has ... commentary at the 2016 ASCRS/ASOA Symposium and Congress, which takes place in New Orleans, ... Refractive Surgery and the American Society of Ophthalmic Administrations will be held at the ...
(Date:5/5/2016)... Francisco, CA (PRWEB) , ... May 05, 2016 , ... This weekend, from Friday, May ... will take on steep California terrain at the first Team Semper Fi Mountain Bike Camp, ... Joining them will be mountain bike legends Mark Weir and Jason Moeschler, who’ll share pro ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... Business Journalists , led by the Wharton School’s most prominent professors, help ... one-day program at the Wharton School’s San Francisco campus will feature Wharton ...
(Date:5/5/2016)... ... May 05, 2016 , ... Derrin Doty Group has ... of Bremerton, Port Orchard and communities west of Seattle. The insurance provider’s caring team ... local girl who died suddenly due to complications from the flu, that they have ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... , May 4, 2016 ... of the  "Global Actinic Keratosis Market and ... their offering.       (Logo: ... Market and Competitive Landscape Highlights 2016, provides ... Actinic Keratosis epidemiology, Actinic Keratosis market valuations ...
(Date:5/3/2016)... Research and Markets has announced ... Therapy Market Outlook 2020" report to their offering. ... ,Recombinant technology has improved significantly in past years due ... in coming years. Many cancer drugs have been developed ... are also expected to be developed with its help. ...
(Date:5/3/2016)... , May 3, 2016   BIOTRONIK , ... today announced Food and Drug Administration (FDA) approval ... that provides heart failure patients with access to ... also have remote monitoring with daily automatic transmission ... heart rate in response to physiological demands. ...
Breaking Medicine Technology: